NIH SBIR
NIH SBIR Authentication of Key Biological and Chemical Resources: What to Include
Learn what NIH expects in an SBIR resource authentication plan, including cell lines, antibodies, specialty chemicals, and acceptance criteria.
What the NIH resource authentication attachment covers
The NIH SBIR Authentication of Key Biological and/or Chemical Resources attachment explains how your startup will establish the identity and validity of resources essential to its proposed research. A mislabeled cell line, an antibody with unexpected binding, or a variable chemical preparation can undermine an otherwise sound feasibility study. This attachment gives reviewers a concise account of how you will control those risks. For a startup developing a therapeutic, diagnostic, research tool, or biomaterials platform, it connects resource quality directly to the reliability of the evidence your award will generate.
NIH generally limits this attachment to one page. Check the current NIH application instructions and your notice of funding opportunity for the requirements that govern your submission. The attachment belongs in the PHS 398 Research Plan form and applies when key biological or chemical resources are used in the proposed work. NIH describes these resources as materials that may differ between laboratories or over time, may have characteristics that influence research results, and are integral to the research. Use that definition to decide which materials need an authentication plan.
Identify the resources that could change your study conclusions
Start with the experiments supporting each specific aim and identify materials whose identity, composition, or biological properties could materially affect the result. Common examples include cell lines, antibodies, specialty chemicals, and other biologics. A cancer therapeutic project might depend on tumor cell lines with particular mutations. A diagnostic project might depend on capture antibodies and a recombinant reference antigen. A biomaterials study might depend on a polymer with a defined molecular-weight distribution. The relevant question is whether variation in that resource could change the interpretation of a key experiment.
NIH generally excludes standard laboratory reagents that are not expected to vary, such as routine buffers and other common chemicals. Keep the attachment focused by grouping related resources under clear labels, while preserving distinctions that affect the testing method. For each group, identify its source and the property that matters scientifically. Commercial materials can still require verification in the intended application. Supplier documentation is useful evidence, and its adequacy depends on what the supplier actually tested, whether the documentation is lot-specific, and how closely those tests match your proposed use.
Match authentication methods to the scientific risk
For human cell lines, short tandem repeat profiling is a widely used method for confirming identity against an appropriate reference profile. Mycoplasma testing addresses a separate quality risk that can alter growth, metabolism, and experimental responses. A credible plan explains when these checks occur, such as upon receipt, before establishing a working bank, and at defined points during extended culture. Select additional checks around the biology driving the study. If a response depends on a particular mutation or engineered construct, describe how you will verify that feature. For nonhuman cell lines, choose identification methods appropriate to the species and available reference information.
For antibodies, authentication should address specificity in the assay you will actually perform. Evidence from a Western blot may provide limited support for performance in immunohistochemistry or a sandwich immunoassay. Depending on the application, useful approaches include knockout controls, known positive and negative samples, an independent antibody, or an orthogonal measurement. For specialty chemicals, methods such as mass spectrometry, nuclear magnetic resonance, or chromatography may establish identity and purity. Recombinant proteins may also require functional activity testing. Select methods that address the resource’s important failure modes, and explain which checks your team will perform versus those supported by supplier records.
Specify acceptance criteria, timing, and corrective actions
A useful authentication plan allows the research team to decide whether a resource is suitable for an experiment. State acceptance criteria at the level your current development stage supports. Examples include a cell-line identity match under the testing laboratory’s validated criteria, a negative mycoplasma result, or chemical purity meeting a specification justified by the assay. Numerical thresholds should come from relevant standards, validated methods, preliminary work, or a defensible experimental requirement. Different applications can justify different specifications. Explain how each criterion protects the result you intend to measure, especially when impurities or cross-reactivity could create a misleading signal.
Include the testing schedule and what happens when a resource fails. You might quarantine incoming cell stocks until verification is complete, qualify new antibody lots before using them in comparative experiments, or retest a material after a storage interval associated with instability. Assign responsibility to the company, university collaborator, contract laboratory, or other party performing the check. Failed materials should trigger a defined response, such as replacement, requalification, or assessment of affected experiments. Traceable lot numbers, cell-bank identifiers, and test records help the team determine which results remain usable and which experiments require repetition.
Fit the plan into one page and align it with the proposal
Build the attachment around a compact, repeatable structure: resource, source, authentication method, timing, and acceptance or replacement rule. A short paragraph for each resource class often works well. A readable table can also help if it follows NIH formatting requirements. NIH instructs applicants to describe authentication plans here and keep experimental methods and preliminary data in the appropriate research sections. Coordinate the attachment with the Research Strategy so that material names, assay uses, and responsibilities match. Separate issues such as blinding, randomization, statistical power, and biological variables belong in the relevant study-design discussion.
Before submission, check that the work is operationally feasible and reflected in the budget. Testing fees, shipping, replacement materials, and staff effort can matter when several cell lines or reagent lots are involved. Costs depend on the number of resources, testing methods, frequency, and whether services are available internally or require an outside laboratory. Confirm that collaborators have agreed to their assigned checks and that the project schedule allows for qualification before pivotal experiments begin. GrantUp’s PhD-level scientists and former federal reviewers help startups connect these technical details to a coherent NIH application. To discuss your project’s fit and application readiness, book a free eligibility call with GrantUp.
Ready to turn this into a funded proposal?
Book a free 30-minute consultation with a senior grant consultant. We will check your eligibility, match you to the right program, and map out your submission timeline.
Learn more about our approach